Neuros Medical Inc announces two milestones in its QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study.
QUEST is a 180-subject, randomized, double blinded, active sham controlled clinical trial that is being conducted under an Investigational Device Exemption (IDE). It is designed to assess the safety & effectiveness of the Company’s Altius High-Frequency Nerve Block system to treat intractable post-amputation pain.
In December 2020, an independent Data Monitoring Committee successfully completed the final planned interim safety and futility analysis of 80 subjects at the 90-day primary endpoints. In addition, despite the ongoing COVID-19 pandemic, QUEST enrollment now exceeds 100 subjects, and the study is on track for completion of enrollment by the Fall of 2021, a media release from Neuros Medical explains.
“I wish to thank the QUEST investigators and their clinical research teams for a remarkable collective effort during this extremely challenging year. I believe that the Altius therapy, with its unique mechanism of action achieved with High-Frequency Nerve Block (HFNB), has great potential to become an important treatment option for post-amputation phantom and stump pain.”
— Leonardo Kapural MD PhD, Carolinas Pain Institute and National Principal Investigator of the QUEST study
“We join Dr. Kapural in expressing gratitude to the QUEST site clinical research teams for their commitment to both the study as well as to the amputee subjects whom they enrolled. We look forward to completing enrollment this year, a key milestone in our efforts to develop a promising treatment option for this significant unmet medical need.”
— David Veino, Neuros Chief Operating Officer
Neuros Medical Inc is a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain.
[Source(s): Neuros Medical Inc, PR Newswire]
Leg Prosthesis Neurofeedback System Aims to Aid Muscle Control, Pain
TMR Procedure to Help Reduce Phantom Limb Pain Described in Study
Targeted Muscle Reinnervation May Also Help Relieve Amputee Limb Pain